Structure of Valsartan CAS 137862-53-4

Valsartan CAS 137862-53-4

/in , , /by

Identification
Properties
Safety Data
Specifications & Other Information
Links

Identification

CAS Number

137862-53-4

Name

Valsartan

Synonyms

(2S)-3-Methyl-2-(pentanoyl{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}amino)butanoic acid
(2S)-3-Methyl-2-(pentanoyl{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}amino)butanoic acid
(2S)-3-Methyl-2-(pentanoyl{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}amino)butansäure [German]
(S)-N-(1-Carboxy-2-methylprop-1-yl)-N-pentanoyl-N-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]amine
137862-53-4 [RN]
7016
80M03YXJ7I
Acide (2S)-3-méthyl-2-(pentanoyl{[2′-(1H-tétrazol-5-yl)biphényl-4-yl]méthyl}amino)butanoïque [French]
L-Valine, N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]- [ACD/Index Name]
N-(1-Oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valin [German] [ACD/IUPAC Name]
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine [ACD/IUPAC Name]
N-Pentanoyl-N-{[2′-(1H-tétrazol-5-yl)-4-biphénylyl]méthyl}-L-valine [French] [ACD/IUPAC Name]
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valin
N-Pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}valin [German] [ACD/IUPAC Name]
N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)-4-biphenylyl]methyl}valine [ACD/IUPAC Name]
N-Pentanoyl-N-{[2′-(2H-tétrazol-5-yl)-4-biphénylyl]méthyl}valine [French] [ACD/IUPAC Name]
N-Pentanoyl-N-{[2′-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
Valine, N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]- [ACD/Index Name]
Valsartan [INN] [JAN] [USAN] [Wiki]
(2S)-3-Methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(2S)-3-Methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(2S)-3-Methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(S)-2-(N-((2′-(1H-Tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(S)-2-(N-((2`-(1H-Tetrazol-5-yl)-[1,1`-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
(S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
(S)-3-Methyl-2-{pentanoyl-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
(S)-3-Methyl-2-{pentanoyl-[2′-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
(S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[(2′-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]amine
(S)-N-valeryl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-Valeryl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; Diovan; N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; N-pentanoyl-N-{[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
[137862-53-4]
3-Methyl-2-{((S)-pentanoyl)-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
7754038 [Beilstein]
BR-58790
C24H29N5O3
CGP 48933 |
CGP 48933;Diovan;Tareg;CGP48933;CGP-48933
CGP48933
CGP-48933
CGP-48933|Diovan®
Diovan [Wiki]
DIOVAN HCT
Diovan®
EXFORGE
Kalpress
L-Valine, N-(1-oxopentyl)-N-((2′-(1H-tetrazol-5-yl)(1,1′-biphenyl)-4-yl)methyl)-
L-Valine,N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-3-yl]methyl]- (9CI)
L-Valsartan
MFCD00865840 [MDL number]
Miten
N-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine
N-(1-oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
N-(1-Oxopentyl)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-L-valine
N-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
N-pentanoyl-N-{[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl}-L-valine
n-valeryl-n-[2-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-l-valine
Pharmakon1600-01505209
Provas
Tareg
UNII:80M03YXJ7I
UNII-80M03YXJ7I
Vals
Valsartan (Diovan)
valsartan, ???
valsartan, [3h]-
valsatarn
Valtan
YV9455000
YV9455000 [RTECS]

Molecular Structure

Structure of Valsartan CAS 137862-53-4

Structure of Valsartan CAS 137862-53-4

SMILES

CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[nH]nnn3)[C@@H](C(C)C)C(=O)O

StdInChI

InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1

StdInChIKey

ACWBQPMHZXGDFX-QFIPXVFZSA-N

Molecular Formula

C24H29N5O3

Molecular Weight

435.52

MDL Number

MFCD00865840

Safety Data

Hazard Statements

H413

RIDADR

NONH for all modes of transport

WGK Germany

3

Specifications and Other Information of Our Valsartan CAS 137862-53-4

Standard

EP, USP

GMP

CFDA

Basic Patent Situation

US expiry date20120321
EU expiry date20110212 (20110512)
JP expiry date20160219

Package

According to customer requirements to packaging

Storage

Under the room temperature and away from light

Application

Used as the Angiotensin II Receptor Antagonist

Links

This product is sold exclusively through our sales company Watson International Ltd, and please click the link below for details.
http://www.watson-int.com/valsartan-cas-137862-53-4/